Skip to main content

WELLS FARGO & COMPANY/MN

Position in TXG — 10x Genomics, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in TXG

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$2,974,661
-$2,651,471 QoQ
Shares Held
140,116
-59.4% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99.36052984669846.ToString("F0")% Shared 0.ToString("F0")% None 0.6394701533015501.ToString("F0")%

Common Shares in TXG Over Time

Shares Held

Position Value (USD)

Derivatives in TXG

reported options exposure · as of Mar 31, 2022
CallValue
$136,926
CallShares
1,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Health Information Services

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $109,001,430 across 37 Health Information Services names. TXG ranks #7 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 TXG
10x Genomics, Inc.
This page
140,116 $2,974,661

All Filings in TXG

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,974,661 140,116
2025-12-31 $5,626,132 344,950
2025-09-30 $2,830,837 242,159
2025-06-30 $748,923 64,674
2025-03-31 $9,942 1,139
2024-12-31 $20,001 1,393
2024-09-30 $269,332 11,928
2024-06-30 $189,286 9,732
2024-03-31 $643,825 17,155
2023-12-31 $1,492,284 26,667
2023-09-30 $1,594,558 38,656
2023-06-30 $2,517,544 45,085
2023-03-31 $2,101,440 37,667
2022-12-31 $2,590,190 71,081
2022-09-30 $2,553,288 89,652
2022-06-30 $5,839,149 129,042
2022-03-31 $136,926 1,800
2022-03-31 $18,841,624 247,688
2021-12-31 $28,819,439 193,471
2021-09-30 $115,255,684 791,700
2021-06-30 $150,379,377 767,947
2021-03-31 $137,446,513 759,373
2020-12-31 $7,469,965 52,754
2020-09-30 $4,171,916 33,461
2020-06-30 $23,532,736 263,495
2020-03-31 $48,288,899 774,854